These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 7161335)
1. High-performance liquid chromatographic assay of the antineoplastic agent tricyclic nucleoside 5'-phosphate and its disposition in rabbit. Basseches PJ; Durski A; Powis G J Chromatogr; 1982 Dec; 233():227-34. PubMed ID: 7161335 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of LC/MS/MS method for Triciribine and its monophosphate metabolite in plasma and RBC: Application to mice pharmacokinetic studies. Narayanan S; Shandil RK; Ahuja VK; Shanmugam SS; Mahesh K U H; Ramesh N; Surendran N J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122714. PubMed ID: 33962189 [TBL] [Abstract][Full Text] [Related]
3. Reversed-phase high-performance liquid chromatographic determination of tricyclic nucleoside and tricyclic nucleoside 5'-phosphate in biological specimens. Schilcher RB; Young JD; Baker LH J Chromatogr; 1985 Jan; 337(1):55-62. PubMed ID: 3980657 [TBL] [Abstract][Full Text] [Related]
4. Disposition of tricyclic nucleoside-5'-monophosphate in blood and plasma of patients during phase I and II clinical trials. Powis G; Basseches PJ; Kroschel DM; Richardson RL; O'Connell MJ; Kvols LK Cancer Treat Rep; 1986 Mar; 70(3):359-62. PubMed ID: 3955547 [TBL] [Abstract][Full Text] [Related]
5. Phase I evaluation and clinical pharmacology of tricyclic nucleoside 5'-phosphate using a weekly intravenous regimen. Schilcher RB; Haas CD; Samson MK; Young JD; Baker LH Cancer Res; 1986 Jun; 46(6):3147-51. PubMed ID: 3698029 [TBL] [Abstract][Full Text] [Related]
6. Metabolism and disposition of 3-amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene in the rat. Basseches PJ; Powis G Cancer Res; 1984 Sep; 44(9):3672-8. PubMed ID: 6540141 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCN. Wotring LL; Crabtree GW; Edwards NL; Parks RE; Townsend LB Cancer Treat Rep; 1986 Apr; 70(4):491-7. PubMed ID: 3698043 [TBL] [Abstract][Full Text] [Related]
8. Activity of tricyclic nucleoside 5'-phosphate in model systems of human ovarian cancer. Behrens BC; Hamilton TC; Louie KG; Grotzinger KR; McKoy WM; Tsuruo T; Young RC; Ozols RF Invest New Drugs; 1986; 4(4):295-304. PubMed ID: 3583641 [TBL] [Abstract][Full Text] [Related]
9. Exit transport of a cyclic nucleotide from mouse L-cells. Plagemann PG; Erbe J J Biol Chem; 1977 Mar; 252(6):2010-6. PubMed ID: 845157 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of CCRF-CEM human leukemic lymphoblasts by triciribine (tricyclic nucleoside, TCN, NSC-154020). Accumulation of drug in cells and comparison of effects on viability, protein synthesis and purine synthesis. Moore EC; Hurlbert RB; Massia SP Biochem Pharmacol; 1989 Nov; 38(22):4037-44. PubMed ID: 2480791 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of triciribine is necessary for activity against HIV type 1. Ptak RG; Borysko KZ; Porcari AR; Buthod JL; Holland LE; Shipman C; Townsend LB; Drach JC AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1315-22. PubMed ID: 9788672 [TBL] [Abstract][Full Text] [Related]
12. Plasma disposition, metabolism and excretion of the experimental antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the mouse, rat and rabbit. Kestell P; Paxton JW; Rewcastle GW; Dunlop I; Baguley BC Cancer Chemother Pharmacol; 1999; 43(4):323-30. PubMed ID: 10071984 [TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic separation and quantitation of benzisoquinolinedione (Nafidimide) from biological fluids. Lu K; Savaraj N; Newman RA J Chromatogr; 1985 Dec; 345(2):408-12. PubMed ID: 4086609 [No Abstract] [Full Text] [Related]
14. High-performance liquid chromatographic determination of purine and pyrimidine bases, ribonucleosides, deoxyribonucleosides and cyclic ribonucleotides in biological fluids. De Abreu RA; Van Baal JM; De Bruyn CH; Bakkeren JA; Schretlen ED J Chromatogr; 1982 Apr; 229(1):67-75. PubMed ID: 7085835 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P). Moore EC; Hurlbert RB; Boss GR; Massia SP Biochem Pharmacol; 1989 Nov; 38(22):4045-51. PubMed ID: 2480792 [TBL] [Abstract][Full Text] [Related]
17. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
18. Sensitive reversed-phase high-performance liquid chromatographic assay for the antitumor agent benzisoquinolinedione (Nafidimide) employing direct on-column injection of plasma and urine, and its use for pharmacokinetic studies in a dog. Powis G; Kroschel DM; Moore DJ J Chromatogr; 1985 Dec; 345(2):402-7. PubMed ID: 4086608 [No Abstract] [Full Text] [Related]
19. Comparison of two high-performance liquid chromatographic methods for the determination of oxmetidine and its metabolites in plasma, bile and urine samples. Lee RM; McDowall RD J Chromatogr; 1983 Apr; 273(2):335-45. PubMed ID: 6863448 [TBL] [Abstract][Full Text] [Related]
20. Analysis of purine and pyrimidine bases, ribonucleosides, and ribonucleotides by high-pressure liquid chromatography. Nissinen E Anal Biochem; 1980 Aug; 106(2):497-505. PubMed ID: 7447014 [No Abstract] [Full Text] [Related] [Next] [New Search]